Incidence and Proportion of Primary Focal Segmental Glomerulosclerosis (FSGS) among a Racially and Ethnically Diverse Adult Patient Population between 2010 and 2021
Clinical Journal of the American Society of Nephrology · 2025
DOI: 10.2215/cjn.0000000590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, 2025. Verfasst von Mercedes A Munis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Otsuka Pharmaceutical Development and Commercialization.
Abstract (Originalsprache)
Key Points Primary FSGS is a rare immune mediated glomerulopathy that accounted for 16.6% for all FSGS reported biopsies among a diverse patient population. From 2010 to 2021, the standardized incidence of primary FSGS was estimated at 1.7 cases per 100,000 patient-years. The highest incidence of primary FSGS was observed among Black (3.2) and Asian (2.7 cases per 100,000 patient-years) people.
Background
Focal segmental glomerulosclerosis (FSGS) refers to a pattern of glomerular injury but also includes primary FSGS which is considered as an immune-mediated glomerulopathy. We sought to determine the incidence of primary FSGS and proportion of patients with FSGS who have primary FSGS among a large diverse patient population in the United States.
Methods
A cross-sectional study (2010–2021) was performed within an integrated health system in patients (age 18 or older) with biopsy-proven FSGS. Among biopsies with FSGS as the first diagnosis on pathology report, chart reviews were performed to determine primary FSGS, defined as podocyte foot process effacement ≥80% on electron microscopy. The proportion of patients with primary FSGS and annual incidence rate (IR) (per 100,000 patient-years) were calculated. Standardized IR were determined by age, sex, and race and ethnicity based on US population structure of the 5-year (2018–2022) American Community Survey estimates.
Results
We identified 3838 patients with FSGS reported on biopsy. Among 1502 with FSGS as the principal diagnosis, 637 met criteria for primary FSGS (mean [SD] age 55.5 years [17.9], 56.5% male, 35.6% Hispanic, 28.7% White, 17.9% Asian/Pacific Islander, and 16.0% Black). The mean standardized IR (confidence interval) of primary FSGS was 1.7 (0.9 to 2.5) per 100,000 patient-years during the study period. The standardized annual IR ranged from 1.3 to 2.4 per 100,000 patient-years. IR (per 100,000 patient-years) were highest among Black (3.2), Asian (2.7), and Pacific Islander (2.8) patients.
Conclusions
Primary FSGS accounted for 16.6% of biopsy-proven FSGS. Primary FSGS is a likely a rare disease with incidence highest among Black, Asian, and Pacific Islander people. More precise identification of primary FSGS may facilitate work to improve understanding of this glomerulopathy and improve kidney outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
- Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey.
- Visterra Inc., Waltham, Massachusetts.
- Department of Internal Medicine, Downey Medical Center, Downey, California.
- Department of Pathology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
- Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
ORCID-Profile: Qiaoling Chen, T Matthew Hill, Min Zhuo, Teresa N Harrison, John J Sim
Förderung
- Otsuka Pharmaceutical Development and Commercialization
Zitieren
APA
Munis, M. A., Chen, Q., Hill, T. M., Zhuo, M., Schachter, A. D., Bhandari, S. K., Hever, A., Harrison, T. N., Fernandes, A. W., & Sim, J. J. (2025). Incidence and Proportion of Primary Focal Segmental Glomerulosclerosis (FSGS) among a Racially and Ethnically Diverse Adult Patient Population between 2010 and 2021. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000000590
Vancouver
Munis MA, Chen Q, Hill TM, Zhuo M, Schachter AD, Bhandari SK, et al. Incidence and Proportion of Primary Focal Segmental Glomerulosclerosis (FSGS) among a Racially and Ethnically Diverse Adult Patient Population between 2010 and 2021. Clinical Journal of the American Society of Nephrology. 2025. doi:10.2215/cjn.0000000590
BibTeX
@article{Munis2025,
author = {Munis, Mercedes A and Chen, Qiaoling and Hill, T Matthew and Zhuo, Min and Schachter, Asher D and Bhandari, Simran K and Hever, Aviv and Harrison, Teresa N and Fernandes, Ancilla W and Sim, John J},
title = {Incidence and Proportion of Primary Focal Segmental Glomerulosclerosis (FSGS) among a Racially and Ethnically Diverse Adult Patient Population between 2010 and 2021},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2025},
doi = {10.2215/cjn.0000000590}
}
EUVIMED